Forced to sell medications at a loss, rural Texas pharmacies seek new survival tactics
Crystal McEntire lives two lives. Every morning, she wakes up to tend to her family’s ranch near the…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
Mothers ‘Terrified’ as Children Could Lose Treatments After FDA Denials
Mothers from across the country have spoken to Newsweek about their concern for their children after the Food…
I used to be a happy drunk — Ozempic made me a sad one
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Public Views on Prescription Drug Costs: Regulation, Affordability and TrumpRx
Key Takeaways In recent weeks, the Trump administration has renewed focus on lowering the cost of prescription drugs…
FDA under scrutiny: 4 issues facing beleaguered agency
The U.S. Food and Drug Administration (FDA) has faced an unusual convergence of political, scientific, legal and operational…
The era of $199 copycat weight loss drugs is ending — and it could cost patients
After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will…
Battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role
You’ve heard of the little blue pill. Now, a new documentary is turning the spotlight on the pink…
We lost weight on GLP-1 drugs — and then lost our sex drives
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Drivers on 4 prescriptions issued road ‘ban’ warning
Individuals taking four types of prescription medications could be “banned” from the roads, with painkillers and sleeping drugs…
People say these ‘absolutely horrid’ GLP-1 side effects are ‘worth it’ for weight loss
It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful…
Don’t risk your health to get thin, doctors warn as festive season fuels demand for GLP-1 injections
KUALA LUMPUR, Feb 12 — In the weeks leading up to Chinese New Year and Ramadan, a familiar conversation…